Tenderwize
Wróć do wyszukiwania

Delivery of Medicinal Products for the Needs of SBALHZ EAD

СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ НА ХЕМАТОЛОГИЧНИ ЗАБОЛЯВАНИЯ ЕАД·гр. София, Bulgaria·BGN 42.5M·Deadline Jun 07, 2027 · 285 days left·Restricted·Supplies·DPS
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на СБАЛХЗ ЕАД

75/100

Ocena szansy

PromisingMedium complexity
SuppliesDPSOpen
Skąd ta ocena?

Szansa

75 / 100

Złożoność

50 / 100

Czynniki ryzyka

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • BGN 42.5M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of pharmaceutical products for a hematology hospital
  • Dynamic Purchasing System (DPS) with possible additions/changes to product list
Pokaż pełne podsumowanie

This tender is a Dynamic Purchasing System (DPS) for the supply of various pharmaceutical products to the Specialized Hospital for Active Treatment of Hematological Diseases (SBALHZ EAD) in Sofia, Bulgaria. The DPS has a duration of 24 months with a total estimated value of 42,451,813.04 BGN. The procedure is restricted and divided into one lot. Award is based on the lowest price per nomenclature item. Participation requires valid licenses for pharmaceutical production or wholesale, and a narcotic drugs license if applicable. The DPS is open for applications until 7 June 2027. Note: There is an inconsistency regarding EU funding; structured data indicates EU-funded, but the XML notice states no EU funds.

Ryzyka

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must hold valid authorization for manufacture or wholesale of medicinal products (or equivalent for EU/EEA)

Eligibility

  • Declaration of eligibility via ESPD (European Single Procurement Document) in Part IV A

Certifications

  • Must hold narcotic drugs license if offering such products

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Lowest price per nomenclature item.

Zamawiający

Lokalizacja

гр. София, BGR

Profil zamawiającego

Otwórz profil

Identyfikator

200105779

Działalność

Health

Części (1)

LOT-0001

Delivery of Medicinal Products for the Needs of SBALHZ EAD

Supply of various medicinal products as detailed in the technical specification (International Nonproprietary Names, active substance quantity, pharmaceutical form, estimated quantities, and estimated values). The specification may be partially amended during the DPS by adding new products or changing quantities.

SuppliesDPSEU fundedElectronic submission

BGN 42.5M

Szacowana wartość

Lokalizacja

София, Bulgaria

Czas trwania

Jun 2025

Kategoria

Pharmaceutical products

Kryteria udzielenia

Price

Termin

Deadline Jun 07, 2027

Szczegóły zamówienia

Data publikacji
04 Jun 2025
Języki
Bulgarian

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
363187-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3